Skip to main content
    • Hub
    • News
    • Signals
    • Market
    • Economy
    • Learn
    • Channel
    • Company
    • Livestream
    • Grafa TV
    • Quote
    • Assets
    • Quote
    • Settings
    • Asset
    • Signals
    1. Home
    2. quote
    3. au
    4. ape

    Latest news about ape

    Grafa
    2 hours ago

    Aptevo Therapeutics reports 86% clinical benefit rate for Mipletamig in frontline AML

    Read more
    Grafa
    2 hours ago

    Cognition Therapeutics aligns with FDA on registrational path for lewy body dementia treatment

    Read more
    Grafa
    2 hours ago

    MapLight Therapeutics surpasses $450M cash position as key clinical readouts approach

    Read more
    Grafa
    Tech
    3 hours ago

    Immersion swings to Q1 loss as Barnes & Noble Education consolidation reshapes profile

    Read more
    Grafa
    21 hours ago

    Corcept Therapeutics announces FDA approval of Lifyorli™ for platinum-resistant ovarian cancer

    Read more
    • T&Cs
    • Privacy Policy
    • Site Map
    • About
    • Contact

    Connect with us

    Disclaimer

    Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

    Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.

    • Hub
    • News
    • Signals
    • Market
    • Search
    An illustrated text logo for the company Grafa Pty Ltd
    An illustrated text logo for the company Grafa Pty Ltd

    ape price, performance and market data

    Asset not found